Condition: Obstructive Sleep Apnea · Sponsor: Lunair Medical
The purpose of this study is to characterize the upper airway of Latin American subjects who have been diagnosed with moderate/severe obstructive sleep apnea (OSA) and assess response to a neuromodulation therapy to treat OSA.
This description comes directly from the study's public registry record.
Andrea Director of Clinical Operations · 866-675-4430 · andreas@lunairmedical.com
Always discuss trial participation with your own doctor first.
| Sanatorio Americano | Asunción, Paraguay | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06762873